Amr El-Khashab, DPM
Foot & Ankle Surgery · Austin, TXNPI 1336566025
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (31.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Nvision Biomedical Technologies, Inc. at 24.2% of the total. Reporting peaked in 2023 at $11,741 and has fallen 82.8% since, to $2,014 in 2025.
Across 128 payments — averaging $225.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nvision Biomedical Technologies, Inc.$7K
- Kerecis Limited$6K
- In2bones USA, LLC$6K
- Stryker$5K
- Vilex LLC$2K
- Paragon 28, Inc.$1K
- plus $2K from 15 others
What the payments were for
- Consulting fees$9,02531%
- Speaking & faculty fees$5,67520%
- Travel & lodging$9,04931%
- Food & beverage$4,09514%
- Education$1,0003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nvision Biomedical Technologies, Inc. | 5 | $6,981 |
| Kerecis Limited | 6 | $6,035 |
| In2bones USA, LLC | 7 | $5,744 |
| Stryker(2 entities) | 72 | $4,750 |
| Vilex LLC | 8 | $1,860 |
| Paragon 28, Inc. | 4 | $1,499 |
| Linvatec Corporation | 6 | $1,367 |
| Sanara Medtech Inc. | 1 | $147 |
| Amgen | 5 | $83 |
| Bioventus LLC | 2 | $59 |
| Trilliant Surgical LLC. | 1 | $54 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $51 |
| Smith+Nephew | 2 | $35 |
| Theramicro, Inc. | 1 | $33 |
| Treace Medical Concepts, Inc. | 1 | $31 |
| Biotissue Holdings Inc. | 1 | $26 |
| Medinc Of Texas | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Zimmer Biomet | 1 | $17 |
| ETS Wound Care LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$17,889
- Kerecis Omega3 GraftGuide$5,963
- Kerecis Omega3 Marigen$5,963
- Foot and Ankle$4,750
- PitStop$3,544
- HINTERMANN$1,772
- Foot/ankle products$1,771
- CoLink$1,500
- Product Portfolio$1,483
- Hercules$850
- PIT'STOP$775
- AXSOS$716
- ANCHORAGE$716
- ALLOWRAP$716
- INFINITY$647
- ALLOGRAFT$644
- BioBrace 23mm$521
- STAR$475
- Trigon$448
- ICONIX$276
How this compares
$28,844 in reported general payments places this provider in the 85th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 33 | $229 |
| Meloxicam | 15 | $27 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Austin
- Mark DaltonAustin$1.9M
- Andrew EbertAustin$82K
- Pedro CosculluelaAustin$69K
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.